XL184 80mg Pill: orange, capsule/oblong, 19mm
Generic Name: cabozantinib
The pill with imprint XL184 80mg (Orange, Capsule/Oblong, 19mm) has been identified as Cometriq 80 mg and is used for Thyroid Cancer. It belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors and is not a controlled substance.
Images for XL184 80mg
Cometriq
- Generic Name
- cabozantinib
- Imprint
- XL184 80mg
- Strength
- 80 mg
- Color
- Orange
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors, VEGF/VEGFR inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Exelixis, Inc.
- National Drug Code (NDC)
See also:
More about Cometriq (cabozantinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.